@inproceedings{chakraborty-2024-rgat,
    title = "{RGAT} at {S}em{E}val-2024 Task 2: Biomedical Natural Language Inference using Graph Attention Network",
    author = "Chakraborty, Abir",
    editor = {Ojha, Atul Kr.  and
      Do{\u{g}}ru{\"o}z, A. Seza  and
      Tayyar Madabushi, Harish  and
      Da San Martino, Giovanni  and
      Rosenthal, Sara  and
      Ros{\'a}, Aiala},
    booktitle = "Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024)",
    month = jun,
    year = "2024",
    address = "Mexico City, Mexico",
    publisher = "Association for Computational Linguistics",
    url = "https://preview.aclanthology.org/ingest-emnlp/2024.semeval-1.19/",
    doi = "10.18653/v1/2024.semeval-1.19",
    pages = "116--122",
    abstract = "In this work, we (team RGAT) describe our approaches for the SemEval 2024 Task 2: Safe Biomedical Natural Language Inference for Clinical Trials (NLI4CT). The objective of this task is multi-evidence natural language inference based on different sections of clinical trial reports. We have explored various approaches, (a) dependency tree of the input query as additional features in a Graph Attention Network (GAT) along with the token and parts-of-speech features, (b) sequence-to-sequence approach using various models and synthetic data and finally, (c) in-context learning using large language models (LLMs) like GPT-4. Amongs these three approaches the best result is obtained from the LLM with 0.76 F1-score (the highest being 0.78), 0.86 in faithfulness and 0.74 in consistence."
}